CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project focuses on developing multi-target drugs to combat Alzheimer's disease by addressing multiple pathways involved in its progression. It aims to create innovative compounds that can modify key processes in the disease's complex network, moving beyond traditional approaches.
As a result of the aging population of the developed countries, neurodegenerative diseases (NDD) afflict an ever-increasing number of people.
Alzheimer’s disease (AD) is the most prevalent NDD with more than 36 million people currently affected worldwide.
Although AD has been studied for more than a hundred years, its “ultimate” trigger is not yet completely understood.
Focus for over two decades on amyloid beta (Aβ) and tau protein, as targets to develop a neuroprotective medicine to delay Alzh…
SERVICIO MADRILENO DE SALUD
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
